Swipe om te navigeren naar een ander artikel
We aimed to identify subgroups of women with breast cancer who experience different health-related quality of life (HRQOL) patterns during active treatment and survivorship and determine characteristics associated with subgroup membership.
We used data from the third phase of the population-based Carolina Breast Cancer Study and included 2142 women diagnosed with breast cancer from 2008 to 2013. HRQOL was measured, on average, 5 and 25 months post diagnosis. Latent profile analysis was used to identify HRQOL latent profiles (LPs) at each time point. Latent transition analysis was used to determine probabilities of women transitioning profiles from 5 to 25 months. Multinomial logit models estimated adjusted odds ratios (aORs) and 95% confidence intervals for associations between patient characteristics and LP membership at each time point.
We identified four HRQOL LPs at 5 and 25 months. LP1 had the poorest HRQOL and LP4 the best. Membership in the poorest profile at 5 months was associated with younger age aOR 0.95; 0.93–0.96, White race aOR 1.48; 1.25–1.65, being unmarried aOR 1.50; 1.28–1.65 and having public aOR 3.09; 1.96–4.83 or no insurance aOR 6.51; 2.12–20.10. At 25 months, Black race aOR 1.75; 1.18–1.82 was associated with the poorest profile membership. Black race and smoking were predictors of deteriorating to a worse profile from 5 to 25 months.
Our results suggest patient-level characteristics including age at diagnosis and race may identify women at risk for experiencing poor HRQOL patterns. If women are identified and offered targeted HRQOL support, we may see improvements in long-term HRQOL and better breast cancer outcomes.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Hennessy, C. H., Moriarty, D.G., Zack, M.M., Scherr, P.A., & Brackbill, R. (1994). Measuring health-related quality of life for public health surveillance. Public Health Reports (Washington, DC 1974), 109(5), 665–672.
Cho, J., Jung, S. Y., Lee, J. E., Shim, E. J., Kim, N. H., Kim, Z., Sohn, G., Youn, H. J., Kim, K. S., Kim, H., Lee, J. W., & Lee, M. H. (2014). A review of breast cancer survivorship issues from survivors’ perspectives. Journal of Breast Cancer, 17(3), 189–199. doi: 10.4048/jbc.2014.17.3.189. PubMedPubMedCentralCrossRef
Smith, A. W., Alfano, C. M., Reeve, B. B., Irwin, M. L., Bernstein, L., Baumgartner, K., Bowen, D., McTiernan, A., & Ballard-Barbash, R. (2009). Race/ethnicity, physical activity, and quality of life in breast cancer survivors. Cancer epidemiology, biomarkers and prevention: A publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Oncology, 18(2), 656–663. doi: 10.1158/1055-9965.epi-08-0352.
Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., Chou, J. F., Dulko, D., Sit, L., Barz, A., Novotny, P., Fruscione, M., Sloan, J. A., & Schrag, D. (2016). Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 34(6), 557–565. doi: 10.1200/jco.2015.63.0830. CrossRef
Kenne Sarenmalm, E., Browall, M., & Gaston-Johansson, F. (2014). Symptom burden clusters: a challenge for targeted symptom management. A longitudinal study examining symptom burden clusters in breast cancer. Journal of Pain and Symptom Management, 47(4), 731–741. doi: 10.1016/j.jpainsymman.2013.05.012. PubMedCrossRef
Dodd, M. J., Cho, M. H., Cooper, B. A., & Miaskowski, C. (2010). The effect of symptom clusters on functional status and quality of life in women with breast cancer. European Journal of Cancer.
Miaskowski, C., Aouizerat, B. E., Dodd, M., & Cooper, B. (2007). Conceptual issues in symptom clusters research and their implications for quality-of-life assessment in patients with cancer. Journal of the National Cancer Institute Monographs, 37, 39–46. doi: 10.1093/jncimonographs/lgm003. CrossRef
McGee, S. A., Durham, D. D., Tse, C. K., & Millikan, R. C. (2013). Determinants of breast cancer treatment delay differ for African American and White women. Cancer epidemiology, biomarkers and prevention: A publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Oncology, 22(7), 1227–1238. doi: 10.1158/1055-9965.epi-12-1432.
Brady, M. J., Cella, D. F., Mo, F., Bonomi, A. E., Tulsky, D. S., Lloyd, S. R., Deasy, S., Cobleigh, M., & Shiomoto, G. (1997). Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 15(3), 974–986. CrossRef
Peterman, A. H., Fitchett, G., Brady, M. J., Hernandez, L., & Cella, D. (2002). Measuring spiritual well-being in people with cancer: The functional assessment of chronic illness therapy–Spiritual Well-being Scale (FACIT-Sp). Annals of Behavioral Medicine: A Publication of the Society of Behavioral Medicine, 24(1), 49–58. CrossRef
Cella, D., Hahn, E. A., & Dineen, K. (2002). Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 11(3), 207–221. CrossRef
Pinheiro, L. C., Samuel, C. A., Reeder-Hayes, K. E., Wheeler, S. B., Olshan, A. F., & Reeve, B. B. (2016). Understanding racial differences in health-related quality of life in a population-based cohort of breast cancer survivors. Breast Cancer Research and Treatment, 159(3), 535–543. doi: 10.1007/s10549-016-3965-y. PubMedCrossRef
Fraley, C., & Raftery, A. (2007). Model-based methods of classification: Using the mclust Software in chemometrics. Journal of Statistical Software, 18(6), 1–13 CrossRef
McCutcheon, A. L. (1987). Latent class analysis. Beverly Hills, CA: Sage Publications. CrossRef
Collins, L. M. L., Lanza, S. T. (2010). Latent class and latent transition analysis with applications in the social, behavioral and health sciences. Hoboken, NJ: Wiley
Tein, J. Y., Coxe, S., & Cham, H. (2013). Statistical power to detect the correct number of classes in latent profile analysis. Structural Equation Modeling: A Multidisciplinary Journal, 20(4), 640–657. CrossRef
Gibson, W. (1959). Three multivariate models: Factor analysis, latent structure analysis, and latent profile analysis. Psychometrika, 24(3), 229–252. CrossRef
Harper, D. (1972). Local dependence latent structure models. Psychometrika, 37, 53–59. CrossRef
Hagenaars, J. (1988). Latent structure models with direct effects between indicators: Local dependence models. Sociological Methods & Research, 16, 379–405. CrossRef
Lanza, S. T., Patrick, M. E., & Maggs, J. L. (2010). Latent transition analysis: Benefits of a latent variable approach to modeling transitions in substance use. Journal of Drug Issues (National Council of State Boards of Nursing (U. S.)), 40(1), 93–120.
Vermunt, J. (2010). Latent class modeling with covariates: Two improved three-step approaches. Political Analysis, 18, 450–469. CrossRef
Yamaguchi, K. (2000). Multinomial logit latent-class regression models: An analysis of the predictors of gender-role attitudes among Japanese women. American Journal of Sociology, 105, 1702–1740. CrossRef
Ferrell, B. R., Grant, M., Funk, B., Garcia, N., Otis-Green, S., & Schaffner, M. L. (1996). Quality of life in breast cancer. Cancer Practice, 4(6), 331–340. PubMed
Gotay, C. C., Kawamoto, C. T., Bottomley, A., & Efficace, F. (2008). The prognostic significance of patient-reported outcomes in cancer clinical trials. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 26(8), 1355–1363. doi: 10.1200/jco.2007.13.3439. CrossRef
Hershman, D. L., Kushi, L. H., Hillyer, G. C., Coromilas, E., Buono, D., Lamerato, L., Bovbjerg, D. H., Mandelblatt, J. S., Tsai, W. Y., Zhong, X., Jacobson, J. S., Wright, J. D., & Neugut, A. I. (2016). Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: The Breast Cancer Quality of Care Study (BQUAL). Breast Cancer Research and Treatment. doi: 10.1007/s10549-016-3788-x.
Higginson, I. J., & Carr, A. J. (2001). Measuring quality of life: Using quality of life measures in the clinical setting. BMJ (Clinical Research Ed.), 322(7297), 1297–1300. CrossRef
Velikova, G., Booth, L., Smith, A. B., Brown, P. M., Lynch, P., Brown, J. M., & Selby, P. J. (2004). Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 22(4), 714–724. doi: 10.1200/jco.2004.06.078. CrossRef
Jensen, R. E., Snyder, C. F., Abernethy, A. P., Basch, E., Potosky, A. L., Roberts, A. C., Loeffler, D. R., & Reeve, B. B. (2013). Review of electronic patient-reported outcomes systems used in cancer clinical care. Journal of Oncology Practice/American Society of Clinical Oncology. doi: 10.1200/jop.2013.001067.
- Examining health-related quality of life patterns in women with breast cancer
Laura C. Pinheiro
Andrew F. Olshan
Stephanie B. Wheeler
Katherine E. Reeder-Hayes
Cleo A. Samuel
Bryce B. Reeve
- Springer International Publishing